# Treatment of Ocular Surface Inflammations

> **NCT07732855** · — · RECRUITING · sponsor: **Semmelweis University** · enrollment: 50 (estimated)

## Conditions studied

- Ocular Surface Allergy
- Conjunctivitis, Allergic
- Blepharoconjunctivitis

## Interventions

- **DRUG:** Topical Cyclosporine 1%

## Key facts

- **NCT ID:** NCT07732855
- **Lead sponsor:** Semmelweis University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-10
- **Primary completion:** 2026-12
- **Final completion:** 2028-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07732855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07732855, "Treatment of Ocular Surface Inflammations". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07732855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*